Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lipocine (LPCN) Interest Expenses (2018 - 2022)

Lipocine's Interest Expenses history spans 5 years, with the latest figure at $1.0 for Q3 2022.

  • For Q3 2022, Interest Expenses fell 100.0% year-over-year to $1.0; the TTM value through Jun 2023 reached $1.0, down 100.0%, while the annual FY2022 figure was $27098.0, 86.67% down from the prior year.
  • Interest Expenses reached $1.0 in Q3 2022 per LPCN's latest filing, down from $7568.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $223789.0 in Q1 2019 to a low of $1.0 in Q3 2022.
  • Average Interest Expenses over 5 years is $111460.6, with a median of $86070.0 recorded in 2020.
  • Peak YoY movement for Interest Expenses: rose 16.27% in 2019, then crashed 100.0% in 2022.
  • A 5-year view of Interest Expenses shows it stood at $218577.0 in 2018, then decreased by 29.14% to $154881.0 in 2019, then plummeted by 47.62% to $81133.0 in 2020, then plummeted by 60.5% to $32051.0 in 2021, then crashed by 100.0% to $1.0 in 2022.
  • Per Business Quant, the three most recent readings for LPCN's Interest Expenses are $1.0 (Q3 2022), $7568.0 (Q2 2022), and $19529.0 (Q1 2022).